Des questions? Nous sommes là pour vous.

imuno@imunobran.lu

+352 621 707 719

fr

fr
de
en

Études de cas - Fallstudien - Case studies

ImunoBran® = BioBran®

Bladder-Cancer-Study

Bladder-Cancer-Study-1

Colon-Cancer-Study-1-Japan

Leukemia-Study-1-Germany

Herpes-Study-1-Germany

Nephroblastoma-Study-1-Slovakia

Lymphoma-Study-1-Japan

Ovarian-Cancer-Study-1

Diabetes-Study-1-Japan

Diabetes-Study-2-Japan

Diabetes-Study-3-Japan

Hepatitis-B-Study-1-Vietnam

Hepatitis-Study-1-Japan

Hepatitis-C-Study-1-Japan

Hepatitis-C-Study-2-Japan

Hepatitis-C-Study-3-Japan

Lung-Cancer-Study-1-German

Lung-Cancer-Study-1-Japan

Lung-Cancer-Study-2-Germany

Can a synergistic activation of pattern recognition receptors by plant immunomodulators enhance the effect of oncologic therapy? Case Report of a patient with uterus and ovary sarcoma

Rapports de cas de patients cancéreux avec métastases

Controlled pilot study for cancer patients suffering from chronic fatigue syndrome due to chemotherapy treated with BioBran and targeted radiofrequency heat therapy.pdf